OptimizeRx Corp. (OPRX) Tops Q3 Earnings and Revenue Estimates

Core Insights - OptimizeRx Corp. reported quarterly earnings of $0.20 per share, significantly exceeding the Zacks Consensus Estimate of $0.03 per share, marking an earnings surprise of +566.67% [1] - The company achieved revenues of $26.07 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 11.25% and showing a year-over-year increase from $21.31 million [2] - OptimizeRx shares have increased approximately 294.2% year-to-date, outperforming the S&P 500's gain of 15.6% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.32 on revenues of $32.81 million, while the estimate for the current fiscal year is $0.67 on revenues of $107.38 million [7] - The estimate revisions trend for OptimizeRx was mixed prior to the earnings release, resulting in a Zacks Rank 3 (Hold), indicating expected performance in line with the market [6] Industry Context - The Computer - Software industry, to which OptimizeRx belongs, is currently ranked in the top 39% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8] - Another company in the same industry, Magic Software, is expected to report quarterly earnings of $0.29 per share, reflecting a year-over-year increase of +26.1% [9]